U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07720115) titled 'Phase 2 Trial Of S-531011 With RadScopal In Previously Treated Metastatic Colorectal Cancer' on July 17.
Brief Summary: To learn if the experimental drug S-531011 plus RadScopalTM radiation therapy can help to control previously treated metastatic colorectal cancer.
Study Start Date: Jan. 07, 2027
Study Type: INTERVENTIONAL
Condition:
Phase II
S-531011
RadScopal
Metastatic Colorectal Cancer
Intervention:
DRUG: S-531011
Given by IV
RADIATION: HD-XRT
Given by radiation
Recruitment Status: NOT_YET_RECRUITING
Sponsor: M.D. Anderson Cancer Center
Published by HT Digital Content Services with permission from Health Daily Diges...